However, according to the panel, the co-presence of negative PD-L1 and non-adenocarcinoma histology favors the use of the quadruplet regimen compared to the triplet regimen, while other oncologists support the use of CT plus double ICI based on negative PD-L1 expression only, regardless of histology [72]. This evidence concerns the gene CD274 and adenocarcinoma.